Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. by Aiello, A, Delia, D, Borrello, MG, Biassoni, D, Giardini, R, Fontanella, E, Pezzella, F, Pulford, K, Pierotti, M, Della Porta, G

“…Among fresh B-cell non-Hodgkin's lymphomas (B-NHL), most sporadic Burkitt's cases were bcl-2 negative. …”

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. by Brown, P, Ashe, S, Leich, E, Burek, C, Barrans, S, Fenton, J, Jack, A, Pulford, K, Rosenwald, A, Banham, A

“…The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. …”

The miRNA Profile in Non-Hodgkin’s Lymphoma Patients with Secondary Myelodysplasia by Yuliya Andreevna Veryaskina, Sergei Evgenievich Titov, Igor Borisovich Kovynev, Tatiana Ivanovna Pospelova, Igor Fyodorovich Zhimulev

“…Some patients with non-Hodgkin lymphomas (NHLs) may have developed secondary myelodysplasia before therapy. …”
Get full text

Targeting Casein Kinase 1 (CK1) in Hematological Cancers by Pavlína Janovská, Emmanuel Normant, Hari Miskin, Vítězslav Bryja

“…In this review we summarize the recent developments in the understanding of biology and therapeutic potential of the inhibition of CK1 isoforms in the pathogenesis of chronic lymphocytic leukemia (CLL), other non-Hodgkin lymphomas (NHL), myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and multiple myeloma (MM). …”
Get full text

Lymphoma immunotherapy: current status by Roberta eZappasodi, Filippo eDe Braud, Massimo eDi Nicola, Massimo eDi Nicola

“…Indolent B-cell non-Hodgkin lymphomas (B-NHLs), in particular, establish key interactions with the immune microenvironment to ensure prosurvival signals and prevent antitumor immune activation. …”
Get full text

Extramedullary Plasmacytoma of the Frontal Sinus: Case Report and Turkish Literature Review by Ayşegül Verim, Shahrouz Sheidaii, Ömer Bilaç, Çiğdem Tepe Karaca, Barış Naiboğlu

“…Solitary extramedullary plasmacytomas (EMPs) are nonepithelial neoplasms of plasma cell origin categorized among non- Hodgkin lymphomas, without the bone marrow involvement and systemic spread seen in multiple myeloma. …”
Get full text

Inhibition of HIF-1α by Atorvastatin During ¹³¹I-RTX Therapy in Burkitt’s Lymphoma Model by Eun-Ho Kim, Hae Young Ko, A Ram Yu, Hyeongi Kim, Javeria Zaheer, Hyun Ji Kang, Young-Cheol Lim, Kyung Deuk Cho, Hyun-Yoo Joo, Min Kyoung Kang, Jae Jun Lee, Seung-Sook Lee, Hye Jin Kang, Sang Moo Lim, Jin Su Kim

“…Backgrounds: Radioimmunotherapy (RIT) serves as a targeted therapy for non-Hodgkin lymphomas (NHL). Although HIF(Hypoxia-inducible factors)-1α is an important biomarker during radiation therapy, its role in NHL is unclear. …”
Get full text

Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas by Marco Lucioni, Sara Fraticelli, Giovanni Santacroce, Arturo Bonometti, Nicola Aronico, Roberta Sciarra, Marco Vincenzo Lenti, Paola Ilaria Bianchi, Giuseppe Neri, Monica Feltri, Benedetto Neri, Giuseppina Ferrario, Roberta Riboni, Gino Roberto Corazza, Alessandro Vanoli, Luca Arcaini, Marco Paulli, Antonio Di Sabatino

“…The gastrointestinal (GI) tract is the most common extranodal site of occurrence of non-Hodgkin lymphomas. Most GI lymphomas are of B-cell lineage, while T-cell lymphomas are less frequent. …”
Get full text

Immunomodulatory Drugs for the Treatment of B Cell Malignancies by Nikolaos Ioannou, Khushi Jain, Alan G. Ramsay

“…Lenalidomide has delivered favorable clinical outcomes as a single-agent, and in combination therapy leads to durable responses in chronic lymphocytic leukemia (CLL) and several non-Hodgkin lymphomas (NHLs) including follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL), and mantle cell lymphoma (MCL). …”
Get full text

Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL) by Feras M. Ghazawi, Nebras Alghazawi, Michelle Le, Elena Netchiporouk, Steven J. Glassman, Denis Sasseville, Ivan V. Litvinov

“…Cutaneous T-cell lymphomas (CTCL) represent a group of non-Hodgkin lymphomas that primarily affect the skin. The detailed pathogenesis by which CTCL develops remains largely unknown. …”
Get full text

The relationship between Sjogren’s syndrome, systemic sclerosis and lymphoproliferative diseases by V. I. Vasil'ev, B. D. Chal'tsev, V. R. Gorodetskii, S. G. Pal'shina, N. S. Shornikova, L. P. Anan'eva, I. V. Gaiduk, N. V. Kokosadze, N. A. Probatova, A. I. Pavlovskaia, E. B. Rodionova, T. N. Safonova, A. A. Balabina

“…In 3 cases, an induced RD was observed: 1 case of a diffuse, rapidly progressive form of SSc, 2 cases of pSS in combination with a limited form of SSc after chemotherapy and radiation therapy of Hodgkins lymphoma (1), B-cell NHL (1) and CR of the breast (1) respectively. …”
Get full text

Association of gene polymorphism and serum levels of IL-12p40 with the susceptibility to non-Hodgkin’s lymphoma in Iraq by Hassan M Naif

“…Objective Non-Hodgkin lymphomas are a diverse lymphoid neoplasms and it is the sixth most common cancer in the world, but it is well established that immune dysregulation especially by cytokines is one of major risk factors. …”
Get full text

Immunoglobulin G Kappa Lymphoplasmacytic Lymphoma with Associated Al Amyloidosis: A Rare Combination! by Gurpreet Kaur, Preeti Tripathi, Hara Prasad Pati, Seema Tyagi

“…Lymphoplasmacytic lymphoma (LPL) is a low-grade B-cell neoplasm, composed of small B-lymphocytes, plasmacytoid lymphocytes, and plasma cells involving bone marrow and sometimes lymph nodes or spleen and forms 1% of all non-Hodgkin lymphomas. LPL with bone marrow involvement and an Immunoglobulin M (IgM) monoclonal gammopathy of any concentration is designated as Waldenström macroglobulinemia (WM). …”
Get full text

F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report by Nguyen Nghi C, Hueser Christopher N, Kaushik Aarti, Farghaly Hussein R, Osman Medhat M

“…<p>Abstract</p> <p>Introduction</p> <p>Breast lymphoma accounts for less than 1% of all non-Hodgkin's lymphomas and approximately 0.1% of all breast neoplasms. …”
Get full text

BDP1 as a biomarker in serous ovarian cancer by Stephanie Cabarcas‐Petroski, Gabriella Olshefsky, Laura Schramm

“…To date, the TFIIIB specific subunit BDP1 has not been investigated in ovarian cancer but has previously been shown to be deregulated in neuroblastoma, breast cancer, and Non‐Hodgkins lymphoma. Results Using in silico analysis of clinically derived platforms, we report a decreased BDP1 expression as a result of deletion in serous ovarian cancer and a correlation with higher and advanced ovarian stages. …”
Get full text

Attitudes of patients with cancer toward the diagnosis, treatment and prognosis of the disease and their influence on the process of adaptation by Bošković Snežana

“…Patients and methods: Thirty-six patients with gynecological and lung cancers and Hodgkin's lymphomas were asked to answer the questionnaire that had been previously developed for the purpose of this research. …”
Get full text

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation by Satish Shanbhag, Mitchell R Smith, Robert VB Emmons

“…Satish Shanbhag1,2, Mitchell R Smith1, Robert VB Emmons21Department of Medical Oncology, Fox Chase Cancer Center, 2Division of Bone Marrow Transplantation, Temple University, Philadelphia, PA, USAAbstract: Mantle cell lymphoma (MCL) is a type of non-Hodgkins lymphoma (NHL) associated with poor progression-free and overall survival. …”
Get full text

B-Cell Lymphoma Producing IgM Anti-B Antibody: A Case Report by Feiyu Jiang, Tiejun Song, Yingjian Wang, Zhiwei Liu

“…Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphomas (NHLs) worldwide. There have been some studies that lymphoma could affect ABO blood group system and thus affect blood transfusion strategy. …”
Get full text

Lymphoproliferative disorders in Oxford renal transplant recipients. by Bates, W, Gray, D, Dada, M, Chetty, R, Gatter, K, Davies, DR, Morris, P

“… BACKGROUND: Increased cancer incidence, particularly lymphoproliferative disease, is a complication of immunosuppression in organ transplantation. Non-Hodgkin's lymphomas (NHLs) occur frequently during the first year after transplantation, more so in North America than in Europe. …”

Predicting mortality and cost of hematopoeitic stem-cell transplantation by Fábio Rodrigues Kerbauy, Leonardo Raul Morelli, Cláudia Toledo de Andrade, Luis Fernando Lisboa, Miguel Cendoroglo Neto, Nelson Hamerschlak

“…Participants mean age at hematopoietic stem cell-transplantation was 42 (range 1 to 72) years; there were 69 males and 47 females; 30 patients had multiple myeloma; 41 had non-Hodgkin and Hodgkin's lymphomas; 22 had acute leukemia; 6 had chronic leukemia; and 17 had non-malignant disease. …”
Get full text